Patients with melanoma harboring TERT promoter mutation and/or methylation had a shorter recurrence-free and overall survival than melanoma patients without these alterations, although these differences did not reach statistical significance ( P = 0.06 and P = 0.08, respectively).
← all excerpts
Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma.
1
0.0600
0.0600